BeStock  
Stocks › Biotechnology › REPL

Replimune REPL

US equityMarket cap rank #2747Biotechnology
$19.07 −$0.16 (-0.83%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $19.09 +0.10%
Open$18.84
Prev close$19.23
Day range$18.69 – $19.50
Volume1.96M
Market cap$1.81B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-7.8x
CheapRich

Near the bottom of its 5-year range · 17th percentile, 5-year average -5.0x

Price / book10.1x
CheapRich

Near the top of its 5-year range · 96th percentile, 5-year average 2.6x

#4942 of 5329 stocks by PB (1 = cheapest)

P/E over five years

-19x-12x-6x1xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$37.38
Price vs. fair value-49.0%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 10.13 – 2.59 96% (pricier than usual) #4942 of 5329 (1 = cheapest)
PE -7.85 -10.75 -4.98 17% (cheaper than usual) –
PS – 23.59 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on REPL.

Sign in to join the discussion.

Scroll to Top